Hybrid Friday Lecture Series
(open to the Rockefeller and Tri-Institutional communities)
Friday, May 10, 2024
Huda Y. Zoghbi, M.D.
Distinguished Service Professor, Departments of Pediatrics, Molecular and Human Genetics, Neurology and Neuroscience, Baylor College of Medicine; Director, Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital; Investigator, Howard Hughes Medical Institute
Molecular and Neurobiological Studies in Rett Syndrome and MECP2 Disorders
The Joshua Lederberg Distinguished Lecture in Molecular Genetics
Recommended Readings:
Zhou, Jian, et al. “A novel pathogenic mutation of MeCP2 impairs chromatin association independent of protein levels.” Genes & Development 37.19-20 (2023): 883-900.
Trostle, Alexander J., et al. “A Comprehensive and Integrative Approach to MeCP2 Disease Transcriptomics.” International Journal of Molecular Sciences 24.6 (2023): 5122.
Sandweiss, Alexander J., Vicky L. Brandt, and Huda Y. Zoghbi. “Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies.” The Lancet Neurology 19.8 (2020): 689-698.
Lombardi, Laura Marie, Steven Andrew Baker, and Huda Yahya Zoghbi. “MECP2 disorders: from the clinic to mice and back.” The Journal of clinical investigation 125.8 (2015): 2914-2923.
Shahbazian, Mona D., and Huda Y. Zoghbi. “Rett syndrome and MeCP2: linking epigenetics and neuronal function.” The American Journal of Human Genetics 71.6 (2002): 1259-1272.
